The 90 million euros ($94 million) raised by Orbis Medicines in a series A round was not January’s biggest venture investment ...

MSD is in late-stage clinical development for macrocyclic peptide drug MK-0616 (enlicitide decanoate) targeting PCSK9 in patients with hypercholesterolemia. The candidate, which is currently being ...

Mydy and colleagues studied the biosynthesis of a class of macrocyclic peptides found in plants and known for their potential use as therapeutic drugs. They identified a "fascinating new protein ...

The Macrocyclic and Supramolecular Chemistry Group is one of the RSC's many Interest Groups. The Interest Groups are member driven groups which exist to benefit RSC members, and the wider chemical ...